BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34536465)

  • 1. Eye-Preserving Therapies for Advanced Retinoblastoma: A Multicenter Cohort of 1678 Patients in China.
    Zhou C; Wen X; Ding Y; Ding J; Jin M; Liu Z; Wang S; Han M; Yuan H; Xiao Y; Wu L; Wang J; Li Y; Yu J; Wen Y; Ye J; Liu R; Chen Z; Xue S; Lu W; Liao H; Cui J; Zhu D; Lu F; Tang S; Wu Y; Yangkyi T; Zhang G; Wubuli M; Guo H; Wang X; He Y; Sheng X; Wang Q; Luo Y; Fan J; Qi J; Yu Z; Tan J; Liang J; Sun X; Jin L; Yang X; Zhang J; Ji X; Zhao J; Jia R; Fan X
    Ophthalmology; 2022 Feb; 129(2):209-219. PubMed ID: 34536465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic and psychological impact of treatment for unilateral intraocular retinoblastoma.
    Soliman SE; Dimaras H; Souka AA; Ashry MH; Gallie BL
    J Fr Ophtalmol; 2015 Jun; 38(6):550-8. PubMed ID: 25982424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).
    Lumbroso-Le Rouic L; Savignoni A; Levy-Gabriel C; Aerts I; Cassoux N; Salviat F; Gauthier-Villars M; Freneaux P; Brisse H; Dendale R; Esteve M; Doz F; Desjardins L
    J Fr Ophtalmol; 2015 Jun; 38(6):535-41. PubMed ID: 25976136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoblastoma in Jordan, 2003-2013: ocular survival and associated factors.
    Al-Nawaiseh I; Jammal HM; Khader YS; Jaradat I; Barham R
    Ophthalmic Epidemiol; 2014 Dec; 21(6):406-11. PubMed ID: 25317653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Systemic Chemotherapy and Delayed Enucleation on Survival of Children with Advanced Intraocular Retinoblastoma.
    Zhao J; Feng ZX; Wei M; Liu G; Solarte CE; Li B; Wang Y; Zhang C; Gallie BL
    Ophthalmol Retina; 2020 Jun; 4(6):630-639. PubMed ID: 32387053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
    Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH
    JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
    Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Mäusert J; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Lohmann DR; Jöckel KH
    J Clin Oncol; 2016 Sep; 34(26):3183-8. PubMed ID: 27382102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Globe conserving treatment of the only eye in bilateral retinoblastoma.
    Lee V; Hungerford JL; Bunce C; Ahmed F; Kingston JE; Plowman PN
    Br J Ophthalmol; 2003 Nov; 87(11):1374-80. PubMed ID: 14609838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma: Part II: Treatment Success and Globe Salvage.
    Tomar AS; Finger PT; Gallie B; Mallipatna A; Kivelä TT; Zhang C; Zhao J; Wilson MW; Brenna RC; Burges M; Kim J; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català J; Correa-Llano G; Carreras E;
    Ophthalmology; 2020 Dec; 127(12):1733-1746. PubMed ID: 32526306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoblastoma in Victoria, 1976-2000: changing management trends and outcomes.
    Dondey JC; Staffieri S; McKenzie J; Davie G; Elder J
    Clin Exp Ophthalmol; 2004 Aug; 32(4):354-9. PubMed ID: 15281966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of primarily treated group D retinoblastoma.
    Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
    Berry JL; Kogachi K; Aziz HA; McGovern K; Zolfaghari E; Murphree AL; Jubran R; Kim JW
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and outcome of unilateral retinoblastoma.
    Mallipatna AC; Sutherland JE; Gallie BL; Chan H; Héon E
    J AAPOS; 2009 Dec; 13(6):546-50. PubMed ID: 20006813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular preservation in patients with bilateral retinoblastoma before chemotherapy in situ era: A report from a Mexican Retinoblastoma Reference Hospital.
    Del Carmen Bernal-Díaz Z; Murillo-Maldonado MA; Pérez-Villanueva H; Reyes-López A; Ramírez-Ortiz MA
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28625. PubMed ID: 32743978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina.
    Chantada GL; Fandiño AC; Schvartzman E; Raslawski E; Schaiquevich P; Manzitti J
    Pediatr Blood Cancer; 2014 May; 61(5):821-6. PubMed ID: 24243706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary Update of Retinoblastoma in China: Three-Decade Changes in Epidemiology, Clinical Features, Treatments, and Outcomes.
    Luo Y; Zhou C; He F; Fan J; Wen X; Ding Y; Han Y; Ding J; Jin M; Liu Z; Wang S; Han M; Yuan H; Sun H; Xiao Y; Wu L; Wang J; Li Y; Yang H; Yu J; Gong J; Xu Y; Wen Y; Gao Z; Mei L; Ye J; Liu H; Chen Z; Xue S; Liu R; Chen H; Lu W; Liao H; Guo Q; Cui J; Zhu D; Lu F; Tang S; Wu Y; Yangkyi T; Guanghong Z; Wubuli M; Huiyu G; Wang X; He Y; Sheng X; Wang Q; Tan J; Liang J; Sun X; Zhang J; Ji X; Jin L; Zhao J; Yang X; Jia R; Fan X
    Am J Ophthalmol; 2022 Apr; 236():193-203. PubMed ID: 34626572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.
    Naseripour M; Nazari H; Bakhtiari P; Modarres-zadeh M; Vosough P; Ausari M
    Br J Ophthalmol; 2009 Jan; 93(1):28-32. PubMed ID: 18952647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoreduction for unilateral retinoblastoma.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
    Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.
    Luna-Fineman S; Chantada G; Alejos A; Amador G; Barnoya M; Castellanos ME; Fu L; Fuentes-Alabi S; Girón V; Goenz MA; Maldonado C; Méndez G; Morales RA; Ortiz R; Sanchez G; Wilson M; Rodríguez-Galindo C
    J Clin Oncol; 2019 Nov; 37(31):2875-2882. PubMed ID: 31536438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.